Reimagining Cancer Treatment with Superior Targeted Radiotherapy
Our technology combines 211-Astatine, the most druggable alpha-emitting radioisotope, with our proprietary Radiobody™ targeting molecules. This innovative approach ensures precise radiation delivery, destroying tumor cells by breaking their DNA strands without harming surrounding healthy cells.
Learn more about our RadioBodies™
Welcome to the future of cancer treatment
Our innovative approach tackles the challenges of cancer treatment by harnessing the power of radiation and targeted delivery using multivalent single-domain antibodies.
We aim to deliver more effective treatment options while minimizing side effects and improving patient outcomes.
